pharma-company /Medicinal products /Active ingredients

Rx · PZN 07424364, 07424370

KALYMIN retard 180 mg prolonged-release tablets

German trade nameKALYMIN retardiert 180 mg Retardtabletten

Active ingredientPyridostigmineSubstance (DE)PyridostigminPharmaceutical formProlonged-release tablets

Consistently available

9.5

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Average purchase price (B2B)

~ €157

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

KALYMIN retard 180 mg prolonged-release tablets is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

KALYMIN retard 180 mg prolonged-release tablets contains the active ingredient Pyridostigmine (German Pyridostigmin) and comes as Prolonged-release tablets. 2 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 8.7 to 9.5 out of 10. The best-available pack was consistently available.


Pack sizes · 2 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
074243709.39.5~ €209
074243649.48.7~ €105

We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 2 recorded PZNs.